Grasmuk H, Nolan R D, Drews J
Eur J Biochem. 1976 Aug 16;67(2):421-31. doi: 10.1111/j.1432-1033.1976.tb10707.x.
Highly purified 3H-labelled elongation factor 1 (EF-1) from Krebs II mouse ascites tumour cells was separated into biologically active monomeric and aggregate forms of the enzyme by either gradient centrifugation or gel filtration. When corrected for their content of inactive enzyme both forms of the factor were found to be equally active whether tested in the binding or synthesis reaction. The only form of the enzyme found bound to ribosomes was the monomer; it was therefore concluded that the aggregate form of the enzyme must first dissociate before it reacts with the ribosome. The stoichiometry of the aminoacyl-tRNA binding reaction to ribosomes in the presence of guanosine nucleotides was also studied. It was found that one molecule of aminoacyl-tRNA and of Guo-5'-P2-CH2-P is bound per molecule of EF-1 bound to the ribosome. Following interaction with a release from, the ribosomes, EF-1 was found to be predominantly monomeric.
从克雷布斯II型小鼠腹水肿瘤细胞中高度纯化的3H标记延伸因子1(EF-1),通过梯度离心或凝胶过滤被分离成该酶具有生物活性的单体形式和聚合体形式。当根据它们所含无活性酶进行校正后,发现无论是在结合反应还是合成反应中进行测试,这两种形式的因子活性相同。唯一被发现与核糖体结合的酶形式是单体;因此得出结论,该酶的聚合体形式在与核糖体反应之前必须先解离。还研究了在鸟苷核苷酸存在下氨酰-tRNA与核糖体结合反应的化学计量关系。发现每分子与核糖体结合的EF-1会结合一分子氨酰-tRNA和一分子Guo-5'-P2-CH2-P。与核糖体释放物相互作用后,发现EF-1主要为单体形式。